Pensions and other post-retirement benefit obligations	6 Months Ended
Jun. 30, 2023
Post-retirement and other defined benefit schemes
Pensions and other post-retirement benefit obligations	Note 5: Pensions and other post-retirement benefit obligations During the six months ended 30 June 2023, AstraZeneca Pharmaceuticals PLP terminated its main defined benefit pension plan. A total of $839m of pension obligations were discharged from the scheme, $142m of which was settled via a cash payment to the participants and the remaining $697m was transferred to an external insurer via a buy-out. At 30 June 2023, the plan contained immaterial residual assets and obligations which are expected to be discharged by the end of 2023, with minimal impact to the income statement.

Pensions and other post-retirement benefit obligations

6 Months Ended

Jun. 30, 2023

Post-retirement and other defined benefit schemes

Pensions and other post-retirement benefit obligations

Note 5: Pensions and other post-retirement benefit obligations

During the six months ended 30 June 2023, AstraZeneca Pharmaceuticals PLP terminated its main defined benefit pension plan. A total of $839m of pension obligations were discharged from the scheme, $142m of which was settled via a cash payment to the participants and the remaining $697m was transferred to an external insurer via a buy-out. At 30 June 2023, the plan contained immaterial residual assets and obligations which are expected to be discharged by the end of 2023, with minimal impact to the income statement.